Cigarette Smoke May Increase Microbial Virulence
David C. Holzman
David C. Holzman writes on science, medicine, energy, economics, and cars from Lexington and Wellfleet, MA. His work has appeared in Smithsonian, The Atlantic Monthly, and the Journal of the National Cancer Institute.
Cigarette smoke has long been known to aggravate respiratory infections. A new study expands the potential health effects to a new front, showing that acute in vitro exposure of Staphylococcus aureus to cigarette smoke promoted biofilm formation and adhesion to human cells.1 The active agents behind this boost in activity appeared to be reactive oxygen species (such as hydrogen peroxide), which are linked not just to cigarette smoke but also vehicular exhaust and biomass smoke. The research was conducted by Ritwij Kulkarni, a postdoctoral researcher in the laboratory of Adam Ratner at the Columbia University Department of Pediatrics.
The new research “may in part explain the strong association between cigarette smoke exposure and respiratory tract infections,” says Janet Lee, an associate professor of medicine at the University of Pittsburgh Medical Center, who was not a collaborator on the study. Earlier research had linked cigarette smoke with biofilm formation,2 but this is the first to examine potential underlying mechanisms, she says.
In the current study, the researchers exposed multiple strains of cultured S. aureus to various concentrations of cigarette smoke by bubbling the smoke into the growth medium. Biofilm formation increased in exposed S. aureus in a dose-dependent fashion. Exposed bacteria also showed increased binding to human fibronectin and lung epithelial cells, compared with controls. Fibronectin is a cell-surface protein that aids in cellular adhesion, among other roles. Bacteria may bind to fibronectin in order to invade human cells.
Exposure to hydrogen peroxide alone also induced biofilm production, whereas spiking cigarette smoke with the antioxidant N-acetyl cysteine interrupted its ability to induce biofilm formation. These observations suggest that an oxidant-dependent pathway is triggered by smoke, leading to enhanced biofilm formation.
The paper is part of a new but rapidly expanding literature. Noam A. Cohen, an assistant professor in the Department of Otorhinolaryngology, Head and Neck Surgery at the University of Pennsylvania, has investigated cigarette smoke’s effect on multiple species of bacteria at once. The bacteria were isolated from sinonasal passages of patients with chronic sinusitis, both smokers and nonsmokers. Cigarette smoke exposure was associated with increased biofilm formation among all species of bacteria, but more so among those isolated from smokers than in those from nonsmokers.2
Cohen praises the Columbia study and says the new work suggests tobacco smoke may “convert the bacteria to a more aggressive form.” But more studies are needed to confirm the findings and determine whether enhanced biofilm formation translates into greater microbial pathogenicity or persistence; Cohen’s own data suggest that cessation of smoke exposure reverses the boost in biofilm formation.2 Furthermore, the use of cigarette smoke extract for in vitro studies has not been standardized.
The relevance of all these findings to human environmental health is broad, says Lee, a clinician with an interest in how cigarette smoke alters immune cell populations. “Cigarette smoke has been linked to a number of diseases, such as oral gingivitis, chronic rhinosinusitis, and chronic lung diseases,” she says, and epidemiologic evidence suggests that exposure to secondhand smoke increases the risk of S. aureus colonization in children.3 Other new findings show that cigarette smoke enhances biofilm production of Pseudomonas aeruginosa4 and Streptococcus pneumoniae,5 two very important respiratory pathogens. “But the pathogenic mechanisms are still not well understood,” Lee says, calling the new research “an important step in identifying which genes are involved.”
All this work may have particular relevance for patients with cardiovascular disease. “This could definitely be part of the comorbidities they are seeing with these patients that aren’t well explained by the cardiovascular diseases,” says Jeff G. Leid, an associate professor at of the Center for Microbial Genetics and Genomics at Northern Arizona University.
Cohen adds that cigarette smoke exposures go well beyond the respiratory tree. He explains, “Many of the products of tobacco get into the blood stream and can thus affect bacteria in distant locations”—in the joints, heart, and gastrointestinal tract, for example. Concludes Ratner: “Our environmental exposures don’t just affect us; they affect our bacteria.” Whether this helps us or hurts us, he says, we need to take it into consideration when investigating the health effects of environmental exposures.
1. Kulkarni R, et al. Cigarette smoke increases Staphylococcus aureus biofilm formation via oxidative stress. Infect Immun 80(11):3804–3811 (2012); http://dx.doi.org/10.1128/IAI.00689-12.
2. Goldstein-Daruech N, et al. Tobacco smoke mediated induction of sinonasal microbial biofilms. PLoS ONE 6(1):e15700 (2011); http://dx.doi.org/10.1371/journal.pone.0015700.
3. Bogaert D, et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363(9424):1871–1872 (2004); http://dx.doi.org/10.1016/S0140-6736(04)16357-5.
4. Antunes MB, et al. 2012. Molecular basis of tobacco–induced bacterial biofilms. Otolaryngol Head Neck Surg 147(5):876–884 (2012); http://dx.doi.org/10.1177/0194599812447263.
5. Mutepe ND, et al. 2012. Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin. Eur Respir J 41(2):392–395 (2013); http://dx.doi.org/10.1183/09031936.00213211.
EHP is pleased to announce that it is now operating under a continuous publication workflow! As indicated in a previous announcement, continuous publication allows EHP to post new content online throughout the month, as each paper becomes ready for an issue. This gets content out to our readers much more quickly than the old issue-based model, and unlike our previous Advance Publication model, these are final, edited articles. (more…)
EHP is pleased to announce that Prenatal Exposure to Glycol Ethers and Neurocognitive Abilities in 6-Year-Old Children: The PELAGIE Cohort Study, published in EHP on 14 October 2016, has been selected by the Children’s Environmental Health Network (CEHN) as its May 2017 Article of the Month. CEHN Article of the Month summaries discuss the potential policy implications of current children’s environmental health research. The CEHN summary can be viewed here.
Among the Resources now available on our Children’s Health page is the text of Executive Order 13045, “Protection of Children from Environmental Health Risks and Safety Risks” (21 April 1997). The Executive Order noted the particular vulnerabilities of children to environmental hazards, codified the need to identify and alleviate such risks, and created the President’s Task Force on Environmental Health Risks and Safety Risks to Children to identify data resources and promote research in these areas. As we mark 20 years since the order was enacted, we can see how these efforts have produced important research and mitigation of hazards—a strong base for continued work on behalf of children’s environmental health.